These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 8354046

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
    Monroe EW.
    Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L, Murrieta Aguttes M, Tonet J.
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria.
    Monroe EW, Bernstein DI, Fox RW, Grabiec SV, Honsinger RW, Kalivas JT, Katz HI, Cuss F, Danzig MR, Garvin PR.
    Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial.
    Pons-Guiraud A, Nekam K, Lahovsky J, Costa A, Piacentini A.
    Eur J Dermatol; 2006 Sep; 16(6):649-54. PubMed ID: 17229605
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, Tursi A.
    Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787
    [Abstract] [Full Text] [Related]

  • 10. [Prevalence of food allergy in patients with urticaria-angioedema syndrome].
    Lunardi C, Favari F, Venturini G, Zagni P, Nicolis F, Pacor ML.
    G Ital Dermatol Venereol; 1990 Aug; 125(7-8):319-22. PubMed ID: 2289813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
    Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.
    J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: a double-blind comparison with crossover treatment of nonresponders.
    Prenner BM, Capano D, Harris AG.
    Clin Ther; 2000 Jun; 22(6):760-9. PubMed ID: 10929922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
    Bellioni P, Catalano B, Cervellera G, Filiaci F, Mira E, Carraro A.
    Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of wheal-and-flare suppression among various non-sedating antihistamines and the pharmacologic insights to their efficacy.
    Roongapinun S, Wajajamreon S, Fooanant S.
    J Med Assoc Thai; 2004 May; 87(5):551-6. PubMed ID: 15222528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.